APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prenatal Genetic Screening Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prenatal Genetic Screening Services Market Outlook and Growth Opportunities 2026

16 January 2026203 pages

Choose your research edition.

Industry ResearchPrenatal Genetic Screening Services Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Prenatal Genetic Screening Services Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Prenatal Genetic Screening Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prenatal Genetic Screening Services Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Prenatal Genetic Screening Services Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Prenatal Genetic Screening Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prenatal Genetic Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prenatal Genetic Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prenatal Genetic Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prenatal Genetic Screening Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prenatal Genetic Screening Services market include ACOG, Penn Medicine, Yale New Haven Health, Yale Medicine, PCRM Vancouver Fertility Clinic, Natera, VCGS, Genome Medical and Henry Ford Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Prenatal Genetic Screening Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prenatal Genetic Screening Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prenatal Genetic Screening Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Prenatal Genetic Screening Services market.

Prenatal Genetic Screening Services Segment by Company

ACOG

Penn Medicine

Yale New Haven Health

Yale Medicine

PCRM Vancouver Fertility Clinic

Natera

VCGS

Genome Medical

Henry Ford Health

Advocate Health Care

NJ Perinatal Associates

CENTOGENE

Lehigh Valley Health Network (LVHN)

Genetics.ie

Insight Medical Genetics

The Royal Women's Hospital

Stanford Medicine Children's Health

UCHealth

Atlantic Health System

Children's Hospital Colorado

Prenatal Genetic Screening Services Segment by Type

Prenatal Screening Tests

Prenatal Diagnostic Tests

Prenatal Genetic Screening Services Segment by Application

First-trimester

Second-trimester

Prenatal Genetic Screening Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prenatal Genetic Screening Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Prenatal Genetic Screening Services key companies, revenue, market share, and recent developments.

3. To split the Prenatal Genetic Screening Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Prenatal Genetic Screening Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prenatal Genetic Screening Services significant trends, drivers, influence factors in global and regions.

6. To analyze Prenatal Genetic Screening Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Genetic Screening Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prenatal Genetic Screening Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Genetic Screening Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prenatal Genetic Screening Services industry.

Chapter 3: Detailed analysis of Prenatal Genetic Screening Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Prenatal Genetic Screening Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Prenatal Genetic Screening Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prenatal Genetic Screening Services Industry Trends Table 2. Prenatal Genetic Screening Services Industry Drivers Table 3. Prenatal Genetic Screening Services Industry Opportunities and Challenges Table 4. Prenatal Genetic Screening Services Industry Restraints Table 5. Global Prenatal Genetic Screening Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prenatal Genetic Screening Services Revenue Share by Company (2021-2026) Table 7. Global Prenatal Genetic Screening Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Prenatal Genetic Screening Services Key Company Manufacturing Base & Headquarters Table 9. Global Prenatal Genetic Screening Services Company, Product Type & Application Table 10. Global Prenatal Genetic Screening Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Prenatal Genetic Screening Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Prenatal Screening Tests Table 15. Significant Companies of Prenatal Diagnostic Tests Table 16. Global Prenatal Genetic Screening Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Prenatal Genetic Screening Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Prenatal Genetic Screening Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Prenatal Genetic Screening Services Sales Value Share by Type (2021-2026) Table 20. Global Prenatal Genetic Screening Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of First-trimester Table 22. Significant Companies of Second-trimester Table 23. Global Prenatal Genetic Screening Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Prenatal Genetic Screening Services Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Prenatal Genetic Screening Services Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Prenatal Genetic Screening Services Sales Value Share by Application (2021-2026) Table 27. Global Prenatal Genetic Screening Services Sales Value Share by Application (2027-2032) Table 28. Global Prenatal Genetic Screening Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Prenatal Genetic Screening Services Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Prenatal Genetic Screening Services Sales Value Share by Region (2021-2026) Table 31. Global Prenatal Genetic Screening Services Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Prenatal Genetic Screening Services Sales Value Share by Region (2027-2032) Table 33. Global Prenatal Genetic Screening Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Prenatal Genetic Screening Services Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Prenatal Genetic Screening Services Sales Value Market Share by Country (2021-2026) Table 36. Global Prenatal Genetic Screening Services Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Prenatal Genetic Screening Services Sales Value Market Share by Country (2027-2032) Table 38. ACOG Company Information Table 39. ACOG Business Overview Table 40. ACOG Prenatal Genetic Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. ACOG Prenatal Genetic Screening Services Product Portfolio Table 42. ACOG Recent Development Table 43. Penn Medicine Company Information Table 44. Penn Medicine Business Overview Table 45. Penn Medicine Prenatal Genetic Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Penn Medicine Prenatal Genetic Screening Services Product Portfolio Table 47. Penn Medicine Recent Development Table 48. Yale New Haven Health Company Information Table 49. Yale New Haven Health Business Overview Table 50. Yale New Haven Health Prenatal Genetic Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Yale New Haven Health Prenatal Genetic Screening Services Product Portfolio Table 52. Yale New Haven Health Recent Development Table 53. Yale Medicine Company Information Table 54. Yale Medicine Business Overview Table 55. Yale Medicine Prenatal Genetic Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Yale Medicine Prenatal Genetic Screening Services Product Portfolio Table 57. Yale Medicine Recent Development Table 58. PCRM Vancouver Fertility Clinic Company Information Table 59. PCRM Vancouver Fertility Clinic Business Overview Table 60. PCRM Vancouver Fertility Clinic Prenatal Genetic Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. PCRM Vancouver Fertility Clinic Prenatal Genetic Screening Services Product Portfolio Table 62. PCRM Vancouver Fertility Clinic Recent Development Table 63. Natera Company Information Table 64. Natera Business Overview Table 65. Natera Prenatal Genetic Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Natera Prenatal Genetic Screening Services Product Portfolio Table 67. Natera Recent Development Table 68. VCGS Company Information Table 69. VCGS Business Overview Table 70. VCGS Prenatal Genetic Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. VCGS Prenatal Genetic Screening Services Product Portfolio Table 72. VCGS Recent Development Table 73. Genome Medical Company Information Table 74. Genome Medical Business Overview Table 75. Genome Medical Prenatal Genetic Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Genome Medical Prenatal Genetic Screening Services Product Portfolio Table 77. Genome Medical Recent Development Table 78. Henry Ford Health Company Information Table 79. Henry Ford Health Business Overview Table 80. Henry Ford Health Prenatal Genetic Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Henry Ford Health Prenatal Genetic Screening Services Product Portfolio Table 82. Henry Ford Health Recent Development Table 83. Advocate Health Care Company Information Table 84. Advocate Health Care Business Overview Table 85. Advocate Health Care Prenatal Genetic Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Advocate Health Care Prenatal Genetic Screening Services Product Portfolio Table 87. Advocate Health Care Recent Development Table 88. NJ Perinatal Associates Company Information Table 89. NJ Perinatal Associates Business Overview Table 90. NJ Perinatal Associates Prenatal Genetic Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. NJ Perinatal Associates Prenatal Genetic Screening Services Product Portfolio Table 92. NJ Perinatal Associates Recent Development Table 93. CENTOGENE Company Information Table 94. CENTOGENE Business Overview Table 95. CENTOGENE Prenatal Genetic Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. CENTOGENE Prenatal Genetic Screening Services Product Portfolio Table 97. CENTOGENE Recent Development Table 98. Lehigh Valley Health Network (LVHN) Company Information Table 99. Lehigh Valley Health Network (LVHN) Business Overview Table 100. Lehigh Valley Health Network (LVHN) Prenatal Genetic Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Lehigh Valley Health Network (LVHN) Prenatal Genetic Screening Services Product Portfolio Table 102. Lehigh Valley Health Network (LVHN) Recent Development Table 103. Genetics.ie Company Information Table 104. Genetics.ie Business Overview Table 105. Genetics.ie Prenatal Genetic Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Genetics.ie Prenatal Genetic Screening Services Product Portfolio Table 107. Genetics.ie Recent Development Table 108. Insight Medical Genetics Company Information Table 109. Insight Medical Genetics Business Overview Table 110. Insight Medical Genetics Prenatal Genetic Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Insight Medical Genetics Prenatal Genetic Screening Services Product Portfolio Table 112. Insight Medical Genetics Recent Development Table 113. The Royal Women's Hospital Company Information Table 114. The Royal Women's Hospital Business Overview Table 115. The Royal Women's Hospital Prenatal Genetic Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. The Royal Women's Hospital Prenatal Genetic Screening Services Product Portfolio Table 117. The Royal Women's Hospital Recent Development Table 118. Stanford Medicine Children's Health Company Information Table 119. Stanford Medicine Children's Health Business Overview Table 120. Stanford Medicine Children's Health Prenatal Genetic Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Stanford Medicine Children's Health Prenatal Genetic Screening Services Product Portfolio Table 122. Stanford Medicine Children's Health Recent Development Table 123. UCHealth Company Information Table 124. UCHealth Business Overview Table 125. UCHealth Prenatal Genetic Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. UCHealth Prenatal Genetic Screening Services Product Portfolio Table 127. UCHealth Recent Development Table 128. Atlantic Health System Company Information Table 129. Atlantic Health System Business Overview Table 130. Atlantic Health System Prenatal Genetic Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Atlantic Health System Prenatal Genetic Screening Services Product Portfolio Table 132. Atlantic Health System Recent Development Table 133. Children's Hospital Colorado Company Information Table 134. Children's Hospital Colorado Business Overview Table 135. Children's Hospital Colorado Prenatal Genetic Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Children's Hospital Colorado Prenatal Genetic Screening Services Product Portfolio Table 137. Children's Hospital Colorado Recent Development Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Prenatal Genetic Screening Services Product Image Figure 2. Global Prenatal Genetic Screening Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prenatal Genetic Screening Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Prenatal Genetic Screening Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Prenatal Screening Tests Image Figure 8. Prenatal Diagnostic Tests Image Figure 9. Global Prenatal Genetic Screening Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Prenatal Genetic Screening Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Prenatal Genetic Screening Services Sales Value Share by Type (2021-2032) Figure 12. First-trimester Image Figure 13. Second-trimester Image Figure 14. Global Prenatal Genetic Screening Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Prenatal Genetic Screening Services Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Prenatal Genetic Screening Services Sales Value Share by Application (2021-2032) Figure 17. Global Prenatal Genetic Screening Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Prenatal Genetic Screening Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Prenatal Genetic Screening Services Sales Value (2021-2032) & (US$ Million) Figure 20. North America Prenatal Genetic Screening Services Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Prenatal Genetic Screening Services Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Prenatal Genetic Screening Services Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Prenatal Genetic Screening Services Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Prenatal Genetic Screening Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Prenatal Genetic Screening Services Sales Value (2021-2032) & (US$ Million) Figure 26. South America Prenatal Genetic Screening Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Prenatal Genetic Screening Services Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Prenatal Genetic Screening Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Prenatal Screening Tests
  • Prenatal Diagnostic Tests
Applications
  • First-trimester
  • Second-trimester
Companies covered
  • ACOG
  • Penn Medicine
  • Yale New Haven Health
  • Yale Medicine
  • PCRM Vancouver Fertility Clinic
  • Natera
  • VCGS
  • Genome Medical
  • Henry Ford Health
  • Advocate Health Care
  • NJ Perinatal Associates
  • CENTOGENE
  • Lehigh Valley Health Network (LVHN)
  • Genetics.ie
  • Insight Medical Genetics
  • The Royal Women's Hospital
  • Stanford Medicine Children's Health
  • UCHealth
  • Atlantic Health System
  • Children's Hospital Colorado

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prenatal Genetic Screening Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prenatal Genetic Screening Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Prenatal Genetic Screening Services Market Dynamics
  1. 2.1 Prenatal Genetic Screening Services Industry Trends
  2. 2.2 Prenatal Genetic Screening Services Industry Drivers
  3. 2.3 Prenatal Genetic Screening Services Industry Opportunities and Challenges
  4. 2.4 Prenatal Genetic Screening Services Industry Restraints
3 Prenatal Genetic Screening Services Market by Company
  1. 3.1 Global Prenatal Genetic Screening Services Company Revenue Ranking in 2025
  2. 3.2 Global Prenatal Genetic Screening Services Revenue by Company (2021-2026)
  3. 3.3 Global Prenatal Genetic Screening Services Company Ranking (2024-2026)
  4. 3.4 Global Prenatal Genetic Screening Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Prenatal Genetic Screening Services Company Product Type and Application
  6. 3.6 Global Prenatal Genetic Screening Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Prenatal Genetic Screening Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Prenatal Genetic Screening Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Prenatal Genetic Screening Services Market by Type
  1. 4.1 Prenatal Genetic Screening Services Type Introduction
  2. 4.1.1 Prenatal Screening Tests
  3. 4.1.2 Prenatal Diagnostic Tests
  4. 4.2 Global Prenatal Genetic Screening Services Sales Value by Type
  5. 4.2.1 Global Prenatal Genetic Screening Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Prenatal Genetic Screening Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global Prenatal Genetic Screening Services Sales Value Share by Type (2021-2032)
5 Prenatal Genetic Screening Services Market by Application
  1. 5.1 Prenatal Genetic Screening Services Application Introduction
  2. 5.1.1 First-trimester
  3. 5.1.2 Second-trimester
  4. 5.2 Global Prenatal Genetic Screening Services Sales Value by Application
  5. 5.2.1 Global Prenatal Genetic Screening Services Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Prenatal Genetic Screening Services Sales Value by Application (2021-2032)
  7. 5.2.3 Global Prenatal Genetic Screening Services Sales Value Share by Application (2021-2032)
6 Prenatal Genetic Screening Services Regional Value Analysis
  1. 6.1 Global Prenatal Genetic Screening Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prenatal Genetic Screening Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Prenatal Genetic Screening Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Prenatal Genetic Screening Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prenatal Genetic Screening Services Sales Value (2021-2032)
  7. 6.3.2 North America Prenatal Genetic Screening Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Prenatal Genetic Screening Services Sales Value (2021-2032)
  10. 6.4.2 Europe Prenatal Genetic Screening Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Prenatal Genetic Screening Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Prenatal Genetic Screening Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Prenatal Genetic Screening Services Sales Value (2021-2032)
  16. 6.6.2 South America Prenatal Genetic Screening Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Prenatal Genetic Screening Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Prenatal Genetic Screening Services Sales Value Share by Country, 2025 VS 2032
7 Prenatal Genetic Screening Services Country-level Value Analysis
  1. 7.1 Global Prenatal Genetic Screening Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prenatal Genetic Screening Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Prenatal Genetic Screening Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Prenatal Genetic Screening Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Prenatal Genetic Screening Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Prenatal Genetic Screening Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Prenatal Genetic Screening Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ACOG
  2. 8.1.1 ACOG Company Information
  3. 8.1.2 ACOG Business Overview
  4. 8.1.3 ACOG Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ACOG Prenatal Genetic Screening Services Product Portfolio
  6. 8.1.5 ACOG Recent Developments
  7. 8.2 Penn Medicine
  8. 8.2.1 Penn Medicine Company Information
  9. 8.2.2 Penn Medicine Business Overview
  10. 8.2.3 Penn Medicine Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Penn Medicine Prenatal Genetic Screening Services Product Portfolio
  12. 8.2.5 Penn Medicine Recent Developments
  13. 8.3 Yale New Haven Health
  14. 8.3.1 Yale New Haven Health Company Information
  15. 8.3.2 Yale New Haven Health Business Overview
  16. 8.3.3 Yale New Haven Health Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Yale New Haven Health Prenatal Genetic Screening Services Product Portfolio
  18. 8.3.5 Yale New Haven Health Recent Developments
  19. 8.4 Yale Medicine
  20. 8.4.1 Yale Medicine Company Information
  21. 8.4.2 Yale Medicine Business Overview
  22. 8.4.3 Yale Medicine Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Yale Medicine Prenatal Genetic Screening Services Product Portfolio
  24. 8.4.5 Yale Medicine Recent Developments
  25. 8.5 PCRM Vancouver Fertility Clinic
  26. 8.5.1 PCRM Vancouver Fertility Clinic Company Information
  27. 8.5.2 PCRM Vancouver Fertility Clinic Business Overview
  28. 8.5.3 PCRM Vancouver Fertility Clinic Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PCRM Vancouver Fertility Clinic Prenatal Genetic Screening Services Product Portfolio
  30. 8.5.5 PCRM Vancouver Fertility Clinic Recent Developments
  31. 8.6 Natera
  32. 8.6.1 Natera Company Information
  33. 8.6.2 Natera Business Overview
  34. 8.6.3 Natera Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Natera Prenatal Genetic Screening Services Product Portfolio
  36. 8.6.5 Natera Recent Developments
  37. 8.7 VCGS
  38. 8.7.1 VCGS Company Information
  39. 8.7.2 VCGS Business Overview
  40. 8.7.3 VCGS Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 VCGS Prenatal Genetic Screening Services Product Portfolio
  42. 8.7.5 VCGS Recent Developments
  43. 8.8 Genome Medical
  44. 8.8.1 Genome Medical Company Information
  45. 8.8.2 Genome Medical Business Overview
  46. 8.8.3 Genome Medical Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genome Medical Prenatal Genetic Screening Services Product Portfolio
  48. 8.8.5 Genome Medical Recent Developments
  49. 8.9 Henry Ford Health
  50. 8.9.1 Henry Ford Health Company Information
  51. 8.9.2 Henry Ford Health Business Overview
  52. 8.9.3 Henry Ford Health Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Henry Ford Health Prenatal Genetic Screening Services Product Portfolio
  54. 8.9.5 Henry Ford Health Recent Developments
  55. 8.10 Advocate Health Care
  56. 8.10.1 Advocate Health Care Company Information
  57. 8.10.2 Advocate Health Care Business Overview
  58. 8.10.3 Advocate Health Care Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Advocate Health Care Prenatal Genetic Screening Services Product Portfolio
  60. 8.10.5 Advocate Health Care Recent Developments
  61. 8.11 NJ Perinatal Associates
  62. 8.11.1 NJ Perinatal Associates Company Information
  63. 8.11.2 NJ Perinatal Associates Business Overview
  64. 8.11.3 NJ Perinatal Associates Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NJ Perinatal Associates Prenatal Genetic Screening Services Product Portfolio
  66. 8.11.5 NJ Perinatal Associates Recent Developments
  67. 8.12 CENTOGENE
  68. 8.12.1 CENTOGENE Company Information
  69. 8.12.2 CENTOGENE Business Overview
  70. 8.12.3 CENTOGENE Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CENTOGENE Prenatal Genetic Screening Services Product Portfolio
  72. 8.12.5 CENTOGENE Recent Developments
  73. 8.13 Lehigh Valley Health Network (LVHN)
  74. 8.13.1 Lehigh Valley Health Network (LVHN) Company Information
  75. 8.13.2 Lehigh Valley Health Network (LVHN) Business Overview
  76. 8.13.3 Lehigh Valley Health Network (LVHN) Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Lehigh Valley Health Network (LVHN) Prenatal Genetic Screening Services Product Portfolio
  78. 8.13.5 Lehigh Valley Health Network (LVHN) Recent Developments
  79. 8.14 Genetics.ie
  80. 8.14.1 Genetics.ie Company Information
  81. 8.14.2 Genetics.ie Business Overview
  82. 8.14.3 Genetics.ie Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Genetics.ie Prenatal Genetic Screening Services Product Portfolio
  84. 8.14.5 Genetics.ie Recent Developments
  85. 8.15 Insight Medical Genetics
  86. 8.15.1 Insight Medical Genetics Company Information
  87. 8.15.2 Insight Medical Genetics Business Overview
  88. 8.15.3 Insight Medical Genetics Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Insight Medical Genetics Prenatal Genetic Screening Services Product Portfolio
  90. 8.15.5 Insight Medical Genetics Recent Developments
  91. 8.16 The Royal Women's Hospital
  92. 8.16.1 The Royal Women's Hospital Company Information
  93. 8.16.2 The Royal Women's Hospital Business Overview
  94. 8.16.3 The Royal Women's Hospital Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 The Royal Women's Hospital Prenatal Genetic Screening Services Product Portfolio
  96. 8.16.5 The Royal Women's Hospital Recent Developments
  97. 8.17 Stanford Medicine Children's Health
  98. 8.17.1 Stanford Medicine Children's Health Company Information
  99. 8.17.2 Stanford Medicine Children's Health Business Overview
  100. 8.17.3 Stanford Medicine Children's Health Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Stanford Medicine Children's Health Prenatal Genetic Screening Services Product Portfolio
  102. 8.17.5 Stanford Medicine Children's Health Recent Developments
  103. 8.18 UCHealth
  104. 8.18.1 UCHealth Company Information
  105. 8.18.2 UCHealth Business Overview
  106. 8.18.3 UCHealth Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 UCHealth Prenatal Genetic Screening Services Product Portfolio
  108. 8.18.5 UCHealth Recent Developments
  109. 8.19 Atlantic Health System
  110. 8.19.1 Atlantic Health System Company Information
  111. 8.19.2 Atlantic Health System Business Overview
  112. 8.19.3 Atlantic Health System Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Atlantic Health System Prenatal Genetic Screening Services Product Portfolio
  114. 8.19.5 Atlantic Health System Recent Developments
  115. 8.20 Children's Hospital Colorado
  116. 8.20.1 Children's Hospital Colorado Company Information
  117. 8.20.2 Children's Hospital Colorado Business Overview
  118. 8.20.3 Children's Hospital Colorado Prenatal Genetic Screening Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Children's Hospital Colorado Prenatal Genetic Screening Services Product Portfolio
  120. 8.20.5 Children's Hospital Colorado Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst